Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 70.00 | 76.50 | 0.9150 | 0.8792 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 86.00 | 207.00 | 0.4155 | -0.5634 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 184.00 | 207.00 | 0.8889 | 0.6308 | |
| SK-BR-3 | Etoposide | 19.9526 | uM | 5 | 312.50 | 138.75 | 202.00 | 207.00 | 0.9759 | 0.9170 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 181.00 | 207.00 | 0.8744 | 0.5850 | |
| SK-BR-3 | Nilotinib | 0.1 | uM | 5 | 312.50 | 138.75 | 171.00 | 207.00 | 0.8261 | 0.4364 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 5 | 312.50 | 138.75 | 206.00 | 207.00 | 0.9952 | 0.9833 |
| SK-BR-3 | Nilotinib | 10 | uM | 5 | 312.50 | 138.75 | 766.00 | 207.00 | 3.7005 | 18.3035 |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 5 | 312.50 | 138.75 | 156.00 | 207.00 | 0.7536 | 0.2251 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 5 | 312.50 | 138.75 | 158.00 | 207.00 | 0.7633 | 0.2525 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 5 | 312.50 | 138.75 | 251.00 | 207.00 | 1.2126 | 1.7929 |
| SK-BR-3 | PLX-4720 | 1 | uM | 5 | 312.50 | 138.75 | 184.00 | 207.00 | 0.8889 | 0.6308 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 5 | 312.50 | 138.75 | 877.00 | 207.00 | 4.2367 | 23.4043 |
| SK-BR-3 | Nilotinib | 1 | uM | 5 | 312.50 | 138.75 | 147.00 | 207.00 | 0.7101 | 0.1053 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 229.00 | 207.00 | 1.1063 | 1.3825 | |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 5 | 312.50 | 138.75 | 202.00 | 207.00 | 0.9759 | 0.9170 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 5 | 312.50 | 138.75 | 303.00 | 207.00 | 1.4638 | 2.8703 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 5 | 312.50 | 138.75 | 239.00 | 207.00 | 1.1546 | 1.5656 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 5 | 312.50 | 138.75 | 179.00 | 207.00 | 0.8647 | 0.5548 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 5 | 312.50 | 138.75 | 188.00 | 207.00 | 0.9082 | 0.6927 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 5 | 312.50 | 138.75 | 200.00 | 207.00 | 0.9662 | 0.8843 |
| SK-BR-3 | Etoposide | 0.1 | uM | 5 | 312.50 | 138.75 | 196.00 | 207.00 | 0.9469 | 0.8195 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 5 | 312.50 | 138.75 | 239.00 | 207.00 | 1.1546 | 1.5656 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 239.00 | 207.00 | 1.1546 | 1.5656 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 136.00 | 207.00 | 0.6570 | -0.0341 |